שם החברה: Atox Bio

שנת ייסוד: 2003

מספר עובדים:

סקטור: Life sciences

תת סקטור: Biotechnology

פרופיל חברה

Atox Bio is a privately held biotechnology company focused on the discovery and development of novel mechanism-based modulators of co-stimulatory signaling, useful as therapeutics for the treatment of infectious and autoimmune diseases mediated by an excessive Th1-cell response. Atox Bio is now developing products for the treatment of:

• Infectious diseases: Severe sepsis and septic shock, highly lethal and constituting a strong unmet medical need.
• Autoimmune diseases: Rheumatoid arthritis and multiple sclerosis, chronic diseases constituting a strong and as yet unsatisfied medical need.